Vanguard Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8M | Buy |
|
|||||
|
2025
Q1 | $36.3M | Sell |
|
|||||
|
2024
Q4 | $47.8M | Buy |
|
|||||
|
2024
Q3 | $61.7M | Buy |
|
|||||
|
2024
Q2 | $44.3M | Sell |
|
|||||
|
2024
Q1 | $38.7M | Buy |
|
|||||
|
2023
Q4 | $26.7M | Buy |
|
|||||
|
2023
Q3 | $42.6M | Sell |
|
|||||
|
2023
Q2 | $52.5M | Buy |
|
|||||
|
2023
Q1 | $38.2M | Buy |
|
|||||
|
2022
Q4 | $40.1M | Buy |
|
|||||
|
2022
Q3 | $47.5M | Buy |
|
|||||
|
2022
Q2 | $23.3M | Buy |
|
|||||
|
2022
Q1 | $12.3M | Sell |
|
|||||
|
2021
Q4 | $14.2M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Sell |
|
|||||
|
2021
Q2 | $13M | Sell |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $9.64M | Buy |
|
|||||
|
2020
Q3 | $1.32M | Buy |
|
|||||
|
2020
Q2 | $231K | Sell |
|
|||||
|
2020
Q1 | $217K | Sell |
|
|||||
|
2019
Q4 | $378K | Sell |
|
|||||
|
2019
Q3 | $758K | Buy |
|
|||||
|
2019
Q2 | $1.07M | Sell |
|
|||||
|
2019
Q1 | $1.94M | Buy |
|
|||||
|
2018
Q4 | $812K | Sell |
|
|||||
|
2018
Q3 | $5.69M | Buy |
|
|||||
|
2018
Q2 | $7.6M | Buy |
|
|||||
|
2018
Q1 | $4.16M | Buy |
|